Towards an HIV Cure: Industry Collaboration Group
The Towards an HIV Cure: Industry Collaboration Group was established in 2012 to bring together private sector partners, academic cure researchers and funding bodies to support collaboration in HIV cure research and development.
The Cure group facilitates and catalyses dialogue, engagement and collaboration between industry stakeholders and academic, civil society and global health institutions to accelerate scientifically promising and ethical HIV research towards remission and an HIV cure. In 2022, the Cure group joined the Corporate Partnership Programme to broaden and strengthen industry engagement in the global HIV response.
The Cure group specifically focuses on:
- Facilitating collaboration between pharmaceutical industries and smaller biotech and diagnostics firms involved in HIV cure research and development, and enabling their engagement with academia, civil society and global health institutions
- Supporting the design, implementation, conduct and analysis of new cure modalities
- Addressing manufacturing and regulatory issues that may hamper the development of an HIV cure
- Seeking and encouraging the development of initiatives to increase financial support from industry partners for HIV cure research and development
Interested in joining? Please contact cpp@iasociety.org.
Case studies:
Case study 1: bnAbs: From prevention to cure
At IAS 2023, the Vaccine and Cure groups co-hosted a satellite event that focused on the high potential of bnAbs in prevention and cure of HIV and explored how the research and development of bnAbs for HIV prevention can contribute to the use of bnAbs in cure strategies. The satellite examined how efforts in the prevention and cure fields can be shared to develop bnAbs that benefit both areas of research. The session drew 130 participants, generating remarkable engagement: 10,558 impressions and 297 interactions on social media.
Case study 2: Africa HIV cure research: Strengthening industry-community engagement in clinical research
At AIDS 2022, the Cure group hosted a satellite session on how best to engage and involve communities of people living with HIV in end-to-end product development and, in particular, clinical research in Africa. Watch the satellite session here and find the report here.
Case study 3: Monitoring HIV Viral Load during ATI
In 2022, the group hosted a roundtable discussion that explored how best to perform point of care viral load testing in cure research involving analytical treatment interruptions (ATI) in low- and middle-income countries. To access the roundtable report, click here.
Case study 4: Non-invasive measurement of HIV reservoirs
In 2022, the group hosted a workshop to discuss innovative non-invasive technology for the measurement of HIV reservoirs in low- and middle-income countries. To access the workshop report, click here.
Case study 5: Linking community to strategy
In 2021, the Cure group hosted a satellite at IAS 2021, titled “IAS Industry Cure Collaboration Group: Linking community to strategy”. Members discussed cure strategies – where are we and what is in the pipeline – and identified how to engage communities in the next phases of HIV cure clinical studies.
Meet the Cure group members
ICG Steering Group
Haruna Aaron Sunday
Deborah Persaud
Sharon Lewin
ICG Membership
Javier Martinez-Picado
Natalia Laufer
Romas Geleziunas
Sandhya Vasan
Karl Salzwedel
Ex officio – International AIDS Society
Carole Beilleau
Julieta Firmat
Nelli Barrière
Sharon Lewin
